Cargando…
免疫检查点抑制剂相关毒副作用管理之激素的使用
Immunocheckpoint inhibitors (ICIs) activated the patients' tumor immunity to kill the tumor cell, and brought new hope to patients with tumor. However, a series of immunocheckpoint inhibitors related adverse effects (irAEs) may also occur based on immune injury. Glucocorticoids are the basis fo...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817429/ https://www.ncbi.nlm.nih.gov/pubmed/31650942 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.02 |
Ejemplares similares
-
免疫检查点抑制剂风湿性毒副反应诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关感染诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关肺炎的临床诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关皮肤不良反应诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关血液毒性处理的临床诊疗建议
Publicado: (2019)